New shot could reduce surgery and steroids for sinus sufferers
NCT ID NCT06516302
First seen Mar 11, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study tests a new drug called GR1802 in 228 adults with severe chronic sinusitis and nasal polyps. The goal is to see if it can shrink polyps, ease congestion, and reduce the need for surgery or steroid pills. Participants receive injections every two weeks for 13 months and are compared to a placebo group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tongren Hospital, Capital Medical University
Beijing, China
Conditions
Explore the condition pages connected to this study.